A nationwide class action has been filed against pharmaceutical distributors Albers Medical, Inc., and Med-Pro, Inc. on behalf of consumers who allege that the companies repackaged and distributed counterfeit Lipitor and possibly other drugs as well. The action alleges that the companies violated the federal Racketeer Influenced Corrupt Organizations Act (RICO) and the Missouri Merchandising Practices Act in distributing the counterfeit drugs. The action seeks treble damages under the RICO statute, monetary damages under the Merchandising Practices Act, punitive damages, and an order requiring Albers and Med-Pro to place the profits from the sale of counterfeit Lipitor in a trust for the benefit of the class.
Previously, Albers announced May 23, 2003, that it had begun a recall of three lots of counterfeit Lipitor in response to an investigation by the federal Food and Drug Administration (FDA). The recalled lots had been repackaged by Med-Pro, according to an FDA press release. Later, on June 3, the recall was expanded to include an additional six lots, also repackaged by Med-Pro. The action alleges that than 200,000 bottles were recalled.
Allegedly, the counterfeit Lipitor was sold in packages also containing genuine Lipitor, and was often indistinguishable from genuine Lipitor. The action alleges that the counterfeit pills pose a serious threat to the health and well being of the public and consumers of the Lipitor product.
In June 2003, Albers and Med-Pro were sued in federal court in Kansas City, Missouri, by Pfizer, Inc., the manufacturer of Lipitor, for trademark infringement, trademark dilution, counterfeiting, and unfair competition.